Free Trial

Molecular Partners (MOLN) Short Interest Ratio & Short Volume

Molecular Partners logo
$5.08 -0.14 (-2.68%)
(As of 12/20/2024 05:16 PM ET)

Molecular Partners Short Interest Data

Molecular Partners (MOLN) has a short interest of 54,700 shares, representing 0.15% of the float (the number of shares available for trading by the public). This marks a -5.69% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 26,409 shares to cover all short positions.

Current Short Interest
54,700 shares
Previous Short Interest
58,000 shares
Change Vs. Previous Month
-5.69%
Dollar Volume Sold Short
$318,354.00
Short Interest Ratio
2.3 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
40,340,000 shares
Float Size
36,760,000 shares
Short Percent of Float
0.15%
Today's Trading Volume
14,993 shares
Average Trading Volume
26,409 shares
Today's Volume Vs. Average
57%
Short Selling Molecular Partners?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Molecular Partners and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MOLN Short Interest Over Time

MOLN Days to Cover Over Time

MOLN Percentage of Float Shorted Over Time

Molecular Partners Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/202454,700 shares $318,354.00 -5.7%0.2%2.3 $5.82
11/15/202458,000 shares $309,140.00 +1.6%N/A3.2 $5.33
10/31/202457,100 shares $310,624.00 +70.5%N/A3.5 $5.44
10/15/202433,500 shares $165,825.00 +7.4%N/A1.4 $4.95
9/30/202431,200 shares $158,717.52 +4.4%N/A1.9 $5.09
9/15/202429,900 shares $156,078.00 +0.3%N/A1.7 $5.22
8/31/202429,800 shares $169,264.00 -8.9%N/A0.8 $5.68
8/15/202432,700 shares $206,886.36 -53.2%N/A0.9 $6.33
7/31/202469,900 shares $629,100.00 +6.2%N/A1.9 $9.00
7/15/202465,800 shares $413,882.00 -23.8%N/A2.4 $6.29
6/30/202486,300 shares $623,949.00 -25.1%N/A3.2 $7.23
6/15/2024115,200 shares $779,904.00 +134.2%N/A4.6 $6.77
5/31/202449,200 shares $177,120.00 No ChangeN/A7.5 $3.60
5/15/202449,200 shares $182,532.00 -8.0%N/A13.7 $3.71
4/30/202453,500 shares $202,283.50 -5.1%N/A15.7 $3.78
4/15/202456,400 shares $222,780.00 +17.8%N/A18.8 $3.95
3/31/202447,900 shares $201,180.00 -2.2%N/A9.8 $4.20
3/15/202449,000 shares $194,040.00 -12.5%N/A3.7 $3.96
2/29/202456,000 shares $240,800.00 -7.6%N/A4.1 $4.30
2/15/202460,600 shares $282,093.00 +3.6%N/A4.5 $4.66
1/31/202458,500 shares $279,630.00 -13.7%N/A4.4 $4.78
1/15/202467,800 shares $323,406.00 +1,132.7%N/A4.9 $4.77
12/31/20235,500 shares $22,989.45 -11.3%N/A0.4 $4.18
12/15/20236,200 shares $26,102.00 -39.2%N/A2.4 $4.21
11/30/202310,200 shares $42,840.00 +117.0%N/A2.6 $4.20
11/15/20234,700 shares $20,774.00 -4.1%N/A1 $4.42
10/31/20234,900 shares $17,297.00 +2.1%N/A0.9 $3.53
10/15/20234,800 shares $20,884.32 -34.3%N/A1 $4.35
9/30/20237,300 shares $30,222.00 -73.1%N/A1.6 $4.14
9/15/202327,100 shares $123,576.00 +173.7%N/A6 $4.56
8/31/20239,900 shares $59,301.00 +135.7%N/A3.5 $5.99
8/15/20234,200 shares $24,822.00 +23.5%N/A2.1 $5.91
7/31/20233,400 shares $20,349.00 +21.4%N/A2.6 $5.99
7/15/20232,800 shares $18,312.00 -46.2%N/A2.3 $6.54
6/30/20235,200 shares $32,344.00 -3.7%N/A4 $6.22
6/15/20235,400 shares $35,748.00 +54.3%N/A4.2 $6.62
5/31/20233,500 shares $22,470.00 -31.4%N/A2.1 $6.42
5/15/20235,100 shares $33,762.51 -42.7%N/A3.6 $6.62
4/30/20238,900 shares $58,651.00 -60.4%N/A4.9 $6.59
4/15/202322,500 shares $146,925.00 +9.2%N/A10.2 $6.53
This Crypto Is Set to Explode in December (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

3/31/202320,600 shares $124,380.74 +32.1%N/A9.4 $6.04
3/15/202315,600 shares $91,416.00 +2.6%N/A6.2 $5.86
2/28/202315,200 shares $95,000.00 No ChangeN/A4.8 $6.25
2/15/202315,200 shares $97,584.00 -2.6%N/A4.5 $6.42
1/31/202315,600 shares $100,620.00 -1.3%N/A3 $6.45
1/15/202315,800 shares $107,484.24 +22.5%N/A2.8 $6.80
12/30/202212,900 shares $84,495.00 +10.3%N/A1.7 $6.55
12/15/202211,700 shares $80,028.00 -14.0%N/A1.4 $6.84
11/30/202213,600 shares $87,040.00 +9.7%N/A1.5 $6.40
11/15/202212,400 shares $86,056.00 -2.4%N/A1.3 $6.94
10/31/202212,700 shares $79,122.27 -7.3%N/A1.3 $6.23
10/15/202213,700 shares $83,433.00 -12.7%N/A1.5 $6.09
9/30/202215,700 shares $105,033.00 -20.7%N/A1.7 $6.69
9/15/202219,800 shares $124,938.00 -26.4%N/A1.9 $6.31
8/31/202226,900 shares $157,634.00 -9.4%N/A2 $5.86
8/15/202229,700 shares $201,663.00 -34.3%N/A1.6 $6.79
7/31/202245,200 shares $279,788.00 +5.6%N/A1.6 $6.19
7/15/202242,800 shares $270,496.00 -3.4%N/A1.4 $6.32
6/30/202244,300 shares $300,354.00 +13.3%N/A1.5 $6.78
6/15/202239,100 shares $265,489.00 +141.4%N/A1.4 $6.79
5/31/202216,200 shares $123,120.00 +76.1%N/A0.6 $7.60
5/15/20229,200 shares $63,480.00 -47.4%N/A0.4 $6.90
4/30/202217,500 shares $140,875.00 +14.4%N/A1.8 $8.05
4/15/202215,300 shares $292,230.00 -26.8%N/A1.4 $19.10
3/31/202220,900 shares $429,495.00 -54.5%N/A0.5 $20.55
3/15/202245,900 shares $941,409.00 -26.7%N/A1 $20.51
2/28/202262,600 shares $1.51 million -19.4%N/A1.3 $24.15
2/15/202277,700 shares $2.05 million -5.0%N/A1.5 $26.37
1/31/202281,800 shares $2.24 million -40.3%N/A1.4 $27.35
1/15/2022137,000 shares $4.37 million +1,081.0%N/A2.4 $31.89
12/31/202111,600 shares $222,488.00 -32.6%N/A0.4 $19.18
12/15/202117,200 shares $270,040.00 +45.8%N/A0.6 $15.70
11/30/202111,800 shares $165,318.00 -19.2%N/A0.5 $14.01
11/15/202114,600 shares $215,934.00 +78.1%N/A0.7 $14.79
10/29/20218,200 shares $152,602.00 -6.8%N/A0.4 $18.61
10/15/20218,800 shares $174,240.00 -59.5%N/A0.4 $19.80
9/30/202121,700 shares $425,537.00 +14.8%N/A0.9 $19.61
9/15/202118,900 shares $381,024.00 -18.2%N/A0.6 $20.16
8/31/202123,100 shares $484,176.00 +75.0%N/A0.3 $20.96
8/13/202113,200 shares $255,552.00 No ChangeN/A0.1 $19.36

MOLN Short Interest - Frequently Asked Questions

What is Molecular Partners' current short interest?

Short interest is the volume of Molecular Partners shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 54,700 shares of MOLN short. 0.15% of Molecular Partners' shares are currently sold short. Learn More on Molecular Partners' current short interest.

What is a good short interest ratio for Molecular Partners?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOLN shares currently have a short interest ratio of 2.0. Learn More on Molecular Partners's short interest ratio.

What is a good short interest percentage for Molecular Partners?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.15% of Molecular Partners' floating shares are currently sold short.

Is Molecular Partners' short interest increasing or decreasing?

Molecular Partners saw a drop in short interest in the month of November. As of November 30th, there was short interest totaling 54,700 shares, a drop of 5.7% from the previous total of 58,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Molecular Partners' float size?

Molecular Partners currently has issued a total of 40,340,000 shares. Some of Molecular Partners' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Molecular Partners currently has a public float of 36,760,000 shares.

How does Molecular Partners' short interest compare to its competitors?

0.15% of Molecular Partners' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Molecular Partners: uniQure (7.62%), 89bio, Inc. (5.54%), Pliant Therapeutics, Inc. (11.90%), Relay Therapeutics, Inc. (7.13%), Keros Therapeutics, Inc. (5.43%), Anavex Life Sciences Corp. (23.22%), Immunome, Inc. (19.29%), Kura Oncology, Inc. (11.20%), Tyra Biosciences, Inc. (6.79%), Erasca, Inc. (19.73%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Molecular Partners stock?

Short selling MOLN is an investing strategy that aims to generate trading profit from Molecular Partners as its price is falling. MOLN shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Molecular Partners?

A short squeeze for Molecular Partners occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MOLN, which in turn drives the price of the stock up even further.

How often is Molecular Partners' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOLN, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:MOLN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners